RT Journal Article
SR Electronic
T1 Robot-based assessment of HIV-related motor and cognitive impairment for neurorehabilitation
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.30.20223172
DO 10.1101/2020.10.30.20223172
A1 Kevin D. Bui
A1 Carol A. Wamsley
A1 Frances S. Shofer
A1 Dennis L. Kolson
A1 Michelle J. Johnson
YR 2020
UL http://medrxiv.org/content/early/2020/11/03/2020.10.30.20223172.abstract
AB There is a pressing need for strategies to slow or treat the progression of functional decline in people living with HIV. This paper explores a novel rehabilitation robotics approach to measuring cognitive and motor impairment in adults living with HIV, including a subset with stroke. We conducted a cross-sectional study with 21 subjects exhibiting varying levels of cognitive and motor impairment. We developed three robot-based tasks trajectory tracking, N-back, and spatial span – to assess if metrics derived from these tasks were sensitive to differences in subjects with varying levels of executive function and upper limb motor impairments. We also examined if these metrics could estimate clinical cognitive and motor scores. The results showed that the average sequence length on the robot-based spatial span task was the most sensitive to differences between subjects’ cognitive and motor impairment levels. We observed strong correlations between robot-based measures and clinical cognitive and motor assessments relevant to the HIV population, such as the Color Trails 1 (rho = 0.83), Color Trails 2 (rho = 0.71), Digit Symbol – Coding (rho = 0.81), Montreal Cognitive Assessment – Executive Function subscore (rho = 0.70), and Box and Block Test (rho = 0.74). Importantly, our results highlight that gross motor impairment may be overlooked in the assessment of HIV-related disability. This study shows that rehabilitation robotics can be expanded to new populations beyond stroke, namely to people living with HIV and those with cognitive impairments.Competing Interest StatementMichelle Johnson is a co-founder of Recupero Robotics, LLC, which is commercializing the rehabilitation robot system used in the study.Clinical TrialStudy was not a clinical trialFunding StatementThis work was made possible through core services and support from the National Institute Of Neurological Disorders and Stroke of the National Institutes of Health (T32NS091006); the University of Pennsylvania Center for AIDS Research (P30AI 045008); the University of Pennsylvania Center for Biomedical Image Comput- ing and Analytics; and the University of Pennsylvania Departments of Bioengineering and Physical Medicine and Rehabilitation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of Pennsylvania IRB Protocol #823511All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDe-identified data is available upon request, and will be available as a repository soon.